bioRxivMicrobiologyPreprint
MAVS signaling is required for clearance of chikungunya heart infection and prevention of chronic inflammation in vascular tissue
M. G. Noval, S. N. Spector, E. Bartnicki, F. Izzo, N. Narula, S. T. Yeung, P. Damani-Yokota, M. Z. Dewan, V. Mezzano, B. A. Rodriguez-Rodriguez, C. Loomis, K. M. Khanna, K. A. Stapleford
Abstract
Chikungunya virus (CHIKV) infection has been associated with severe cardiac manifestations, yet, how CHIKV infection leads to heart disease remains unknown. Here, we leveraged both mouse models and human primary cells to define the mechanisms of CHIKV heart infection. We found that CHIKV actively replicates in cardiac fibroblasts and is cleared without significant tissue damage through the induction of a local type-I interferon response from both infected and non-infected cardiac cells. Importantly, signaling through the mitochondrial antiviral-signaling protein (MAVS) is required for viral clearance from the heart. In the absence of MAVS, persistent infection leads to focal myocarditis and major vessel vasculitis persisting for up to 60 days post-infection, suggesting CHIKV can lead to vascular inflammation and potential long-lasting cardiovascular complications. This study provides a model of CHIKV cardiac infection and mechanistic insight into CHIKV-induced heart disease, underscoring the importance of monitoring cardiac function in patients with CHIKV infections.
- organism: mouse
- organism: human
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- IL-17A Restrains Antiviral Immunity to Promote Chikungunya Virus Infection and Pathogenesis in the Heart
Shazeed-Ul Karim, Prince M. D. Denyoh, … Fengwei Bai·bioRxiv·Aug 9, 2026
- Differential restriction of chikungunya virus in primary human cardiac endothelial cells occurs at multiple steps in the viral life cycle
Sophie N. Spector, Maria Gabriela Noval, Kenneth A. Stapleford·PLoS neglected tropical diseasesPeer-reviewed·Mar 10, 2025
- MK2a inhibitor CMPD1 abrogates chikungunya virus infection by modulating actin remodeling pathway
S. Chattopadhyay, P. Mamidi, … S. Chattopadhyay·bioRxiv·May 26, 2021
- Chikungunya Virus Infection of Monocytes Generates a Persistent Macrophage Reservoir That Promotes IFN-π/IL-27-STAT1- and NF-κB-Driven Chronic Arthritis
Juan Felipe Valdés‐López, Yordi Sebastián Tamayo-Molina, … Silvio Urcuqui Inchima·bioRxiv·Sep 30, 2026
- Telmisartan restricts Chikungunya virus infection in vitro and in vivo through the AT1/ PPAR-γ/MAPKs pathways
S. De, P. Mamidi, … S. Chattopadhyay·bioRxiv·Jul 30, 2021
- Chikungunya virus infection disrupts lymph node lymphatic endothelial cell composition and function via MARCO
C. Lucas, R. Sheridan, … T. Morrison·JCI InsightPeer-reviewed·Jan 9, 2024